BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24014885)

  • 21. Rising incidence of primary liver cancer in Brunei Darussalam.
    Chong RJ; Abdullah MS; Hossain MM; Telisinghe PU; Chong VH
    Asian Pac J Cancer Prev; 2013; 14(6):3473-7. PubMed ID: 23886131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoma of the gallbladder and extrahepatic biliary ducts in Rochester, Minnesota, 1935--1971.
    Maram ES; Ludwig J; Kurland LT; Brian DD
    Am J Epidemiol; 1979 Feb; 109(2):152-7. PubMed ID: 425954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
    Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
    World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends.
    Miranda-Filho A; Piñeros M; Ferreccio C; Adsay V; Soerjomataram I; Bray F; Koshiol J
    Int J Cancer; 2020 Aug; 147(4):978-989. PubMed ID: 31922259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program.
    Albores-Saavedra J; Batich K; Hossain S; Henson DE; Schwartz AM
    Ann Diagn Pathol; 2009 Dec; 13(6):378-83. PubMed ID: 19917473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
    Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.
    Kamisawa T; Tu Y; Kuwata G; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Matsukawa M
    Hepatogastroenterology; 2006; 53(72):816-8. PubMed ID: 17153430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholangiocarcinoma Prognosis Varies over Time Depending on Tumor Site and Pathology.
    Kaneko R; Sato Y; Kobayashi Y
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):59-66. PubMed ID: 29557416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
    Goodman MT; Yamamoto J
    Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholangiocarcinoma among workers in the printing industry: using the NOCCA database to elucidate the generalisability of a cluster report from Japan.
    Vlaanderen J; Straif K; Martinsen JI; Kauppinen T; Pukkala E; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Occup Environ Med; 2013 Dec; 70(12):828-30. PubMed ID: 24142991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between vegetable/fruit consumption and gallbladder/bile duct cancer: A population-based cohort study in Japan.
    Makiuchi T; Sobue T; Kitamura T; Ishihara J; Sawada N; Iwasaki M; Sasazuki S; Yamaji T; Shimazu T; Tsugane S
    Int J Cancer; 2017 Mar; 140(5):1009-1019. PubMed ID: 27798952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and mortality trends for biliary tract cancers in Austria.
    Pinter M; Hucke F; Zielonke N; Waldhör T; Trauner M; Peck-Radosavljevic M; Sieghart W
    Liver Int; 2014 Aug; 34(7):1102-8. PubMed ID: 24119058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.
    Kamal H; Sadr-Azodi O; Engstrand L; Brusselaers N
    Hepatology; 2021 Oct; 74(4):2021-2031. PubMed ID: 34018229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing incidence of hepatocellular carcinoma in Japan.
    Okuda K; Fujimoto I; Hanai A; Urano Y
    Cancer Res; 1987 Sep; 47(18):4967-72. PubMed ID: 3040235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence of carcinoma of the gallbladder and bile ducts in Sweden 1958 to 1972.
    Brodén G; Ahlberg J; Bengtsson L; Hellers G
    Acta Chir Scand Suppl; 1978; 482():24-5. PubMed ID: 278423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gallbladder and extrahepatic bile duct carcinoma. Analysis of 1,808 cases.
    Krain LS
    Geriatrics; 1972 Nov; 27(11):111-7. PubMed ID: 5080807
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumours of liver, biliary system and pancreas.
    Hutt MS; Anthony PP
    Recent Results Cancer Res; 1973; 41():57-78. PubMed ID: 4140554
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
    Chuang SC; Lee KT; Tsai KB; Sheen PC; Nagai E; Mizumoto K; Tanaka M
    World J Surg; 2004 Oct; 28(10):995-1000. PubMed ID: 15573254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary liver cancer in Sri Lanka.
    Nagaratnam N; Ramachandra V; Jiffry AJ; Bhuvanendran N
    J Trop Med Hyg; 1984 Aug; 87(4):185-7. PubMed ID: 6097698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tumor grading of the hepatobiliary system].
    Jütte H; Tannapfel A
    Pathologe; 2016 Jul; 37(4):299-303. PubMed ID: 27342594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.